41![Microsoft Word - CCCA5AC4.doc Microsoft Word - CCCA5AC4.doc](https://www.pdfsearch.io/img/221bd3b5d7803b404e7b9ad0d535b909.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-01-05 16:25:57
|
---|
42![ICH S7B Guideline Step 2 Revision The Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals ICH S7B Guideline Step 2 Revision The Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals](https://www.pdfsearch.io/img/4ec7ab87bb2dba2d6ac0e830aedea00e.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-09-10 06:20:27
|
---|
43![Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs](https://www.pdfsearch.io/img/f050105f70a3951b3e561eee3215f531.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-10-17 17:52:11
|
---|
44![Microsoft Word - 04D-0378-EC3-Attach-2.doc Microsoft Word - 04D-0378-EC3-Attach-2.doc](https://www.pdfsearch.io/img/87be1005b89910835aa10f5c4681c721.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-01-05 16:25:58
|
---|
45![inical Evaluation of QT Prolongati 0 Docket 04D-0377, ICH El Docket 04D-0378, ICH S7B, Nonclinical Evaluation of QT Prolongation Page 14 inical Evaluation of QT Prolongati 0 Docket 04D-0377, ICH El Docket 04D-0378, ICH S7B, Nonclinical Evaluation of QT Prolongation Page 14](https://www.pdfsearch.io/img/1a005aa73e931ca4e00c842c0df01ee9.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-01-05 16:25:54
|
---|
46![Genes in Long QT Syndromes Andrew D. Krahn MD FRCPC Coworkers: Michael Gollob MD* George J. Klein MD Genes in Long QT Syndromes Andrew D. Krahn MD FRCPC Coworkers: Michael Gollob MD* George J. Klein MD](https://www.pdfsearch.io/img/78c4c7d4feca96ad4943b6b9a5b5ca7b.jpg) | Add to Reading ListSource URL: www.sads.caLanguage: English - Date: 2013-03-10 20:04:19
|
---|
47![INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL](https://www.pdfsearch.io/img/d801e5917dfe8b0116fddfc324159754.jpg) | Add to Reading ListSource URL: www.ich.orgLanguage: English - Date: 2012-06-22 05:08:05
|
---|
48![Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs](https://www.pdfsearch.io/img/dcf58ebea3dcab37ca76f031561c010f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2006-11-13 08:05:27
|
---|
49![Heart Rhythm[removed], 60 – 64 www.heartrhythmjournal.com Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome Heart Rhythm[removed], 60 – 64 www.heartrhythmjournal.com Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome](https://www.pdfsearch.io/img/d0d9c2d6298220ae88dd0af0807d01e5.jpg) | Add to Reading ListSource URL: www.sads.orgLanguage: English - Date: 2010-07-30 19:42:54
|
---|
50![DCRP consult to evaluate nonclinical cardiac safety data for propoxyphene (January 21, 2010 memo) DCRP consult to evaluate nonclinical cardiac safety data for propoxyphene (January 21, 2010 memo)](https://www.pdfsearch.io/img/23d56ec14a385a54a5343171f1a7ab11.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|